Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armbruster

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Immunoassay|January 1, 1992
Characterization of antibodies against human N-terminal parathyroid hormone by epitope mappingJ Tampe, P Broszio, H E Manneck, et al.
Clinical Chemistry|December 4, 1998
Urinary and plasma urodilatin measured by a direct RIA using a highly specific antiserumM Meyer, F P Armbruster, I Maier, et al.
Connective Tissue Research|June 19, 2004
Analysis of human bone sialoprotein in normal and pathological tissues using a monoclonal antibody (BSP 1.2 mab)Gabrielle Cogan, Anil K Bansal, Sarwat Ibrahim, et al.
European Journal of Medical Research|April 22, 2009
The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart diseaseMatthias Heringlake, T Kox, J Poeling, et al.
Annals of the New York Academy of Sciences|October 15, 2013
Endotherapy for and tailored approaches to treating GERD, and refractory GERDG Richard Locke, John Horwhat, Hiroshi Mashimo, et al.
The Journal of Pathology. Clinical Research|February 9, 2018
IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasisMichael Zepp, Marineta Kovacheva, Munkhtsetseg Altankhuyag, et al.
European Journal of Medical Research|April 21, 2001
A sensitive homologous radioimmunoassay for human relaxin-2 (h-RLX-2) based on antibodies characterized by epitope mapping studiesF P Armbruster, H J Grön, I Maier, et al.
Kidney & Blood Pressure Research|July 23, 2013
Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipientsBerthold Hocher, Dominik Oberthür, Torsten Slowinski, et al.
BMJ Nutrition, Prevention & Health|January 30, 2025
Haptoglobin polymorphism, vitamin E and mortality: the Ludwigshafen Risk and Cardiovascular Health StudyGraciela E Delgado, Marcus E Kleber, Angela P Moissl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasisI J Diel, E F Solomayer, M J Seibel, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Immunoassay|January 1, 1992
Characterization of antibodies against human N-terminal parathyroid hormone by epitope mappingJ Tampe, P Broszio, H E Manneck, et al.
Clinical Chemistry|December 4, 1998
Urinary and plasma urodilatin measured by a direct RIA using a highly specific antiserumM Meyer, F P Armbruster, I Maier, et al.
Connective Tissue Research|June 19, 2004
Analysis of human bone sialoprotein in normal and pathological tissues using a monoclonal antibody (BSP 1.2 mab)Gabrielle Cogan, Anil K Bansal, Sarwat Ibrahim, et al.
European Journal of Medical Research|April 22, 2009
The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart diseaseMatthias Heringlake, T Kox, J Poeling, et al.
Annals of the New York Academy of Sciences|October 15, 2013
Endotherapy for and tailored approaches to treating GERD, and refractory GERDG Richard Locke, John Horwhat, Hiroshi Mashimo, et al.
The Journal of Pathology. Clinical Research|February 9, 2018
IDK1 is a rat monoclonal antibody against hypoglycosylated bone sialoprotein with application as biomarker and therapeutic agent in breast cancer skeletal metastasisMichael Zepp, Marineta Kovacheva, Munkhtsetseg Altankhuyag, et al.
European Journal of Medical Research|April 21, 2001
A sensitive homologous radioimmunoassay for human relaxin-2 (h-RLX-2) based on antibodies characterized by epitope mapping studiesF P Armbruster, H J Grön, I Maier, et al.
Kidney & Blood Pressure Research|July 23, 2013
Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipientsBerthold Hocher, Dominik Oberthür, Torsten Slowinski, et al.
BMJ Nutrition, Prevention & Health|January 30, 2025
Haptoglobin polymorphism, vitamin E and mortality: the Ludwigshafen Risk and Cardiovascular Health StudyGraciela E Delgado, Marcus E Kleber, Angela P Moissl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasisI J Diel, E F Solomayer, M J Seibel, et al.
Pageof 7